Growth Metrics

Healthequity (HQY) Change in Receivables (2016 - 2026)

Healthequity has reported Change in Receivables over the past 14 years, most recently at $12.5 million for Q1 2026.

  • For Q1 2026, Change in Receivables rose 10.26% year-over-year to $12.5 million; the TTM value through Jan 2026 reached $5.7 million, down 56.61%, while the annual FY2026 figure was $5.7 million, 56.61% down from the prior year.
  • Change in Receivables for Q1 2026 was $12.5 million at Healthequity, up from $79000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $12.5 million in Q1 2026 and troughed at -$5.8 million in Q3 2023.
  • A 5-year average of $2.2 million and a median of $1.3 million in 2024 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 1971.84% in 2022 and fell as far as 400.0% in 2022.
  • Year by year, Change in Receivables stood at -$2.7 million in 2022, then skyrocketed by 232.84% to $3.6 million in 2023, then tumbled by 148.39% to -$1.7 million in 2024, then skyrocketed by 104.54% to $79000.0 in 2025, then soared by 15663.29% to $12.5 million in 2026.
  • Business Quant data shows Change in Receivables for HQY at $12.5 million in Q1 2026, $79000.0 in Q4 2025, and -$5.1 million in Q3 2025.